Skip to content
healthcare.dev
Get a free key

Edarbi

NDC 60631-040, Azilsartan kamedoxomil, tablet, from Azurity Pharmaceuticals, Inc..

Product NDC
60631-040
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA200796
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60631-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZILSARTAN KAMEDOXOMIL40 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Decreased Blood Pressure [PE]

Package NDCNDC-11Package
60631-040-306063100403030 TABLET in 1 BOTTLE (60631-040-30)
60631-040-77606310040777 TABLET in 1 BOTTLE (60631-040-77)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/52b27c75-9f5a-4816-bafd-dace9d7d2063

  • NADAC price for package 60631004030

    GET /v1/drugs/nadac/60631004030

Use it

Look up 60631-040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60631-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60631-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.